Rebif 22 mcg (Interferon Beta-1a SOLUTION) 22 MCG

REBIF 22 MCG is a subcutaneous solution containing Interferon Beta-1a, used for managing specific medical conditions. This medication is designed to support treatment regimens as prescribed by healthcare professionals.

Strength

22 MCG

Pack Size

3X0.5ML

Manufacturer / TM Owner

EMD SERONO, A DIVISION OF EMD INC., CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REBIF 22 MCG is primarily used in the management of certain neurological conditions. Interferon Beta-1a, the active ingredient, is often incorporated into treatment plans to help modulate the immune system's response. Patients may wonder, 'What is REBIF 22 MCG used for?' Typically, it is utilized in the context of long-term therapeutic strategies.

Side Effects

Common effects of REBIF 22 MCG may include injection site reactions, flu-like symptoms, and fatigue. These effects are generally mild to moderate and may diminish over time as the body adjusts to the medication. Patients should monitor their response and consult their healthcare provider if concerns arise.

Precautions & Warnings

REBIF 22 MCG should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration guidelines to minimize potential risks. Patients with a history of certain medical conditions should discuss their situation with a healthcare professional before starting treatment.

Avoid Interactions

REBIF 22 MCG may interact with other medications, including those that affect the immune system. Alcohol and certain supplements could also influence its effectiveness. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

REBIF 22 MCG is used in the management of specific neurological conditions, often as part of a long-term treatment plan.

REBIF 22 MCG is administered subcutaneously, typically following a prescribed schedule. Patients should receive proper training on self-administration.

Common side effects may include injection site reactions, flu-like symptoms, and fatigue. These effects are usually mild to moderate.

REBIF 22 MCG may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

REBIF 22 MCG should be stored according to the manufacturer's instructions, typically in a refrigerator, to maintain its efficacy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.